SynthesisBMC pharmacology & toxicology2025

Real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies.

Mohammad Amin Karimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.